MEKOPHAR Chemical Pharmaceutical Joint Stock Company Sustainability Profile
MEKOPHAR Chemical Pharmaceutical Joint Stock Company, commonly referred to as MEKOPHAR, is a prominent player in the pharmaceutical industry, headquartered in Vietnam. Established in 1977, the company has made significant strides in the production and distribution of high-quality pharmaceutical products, primarily focusing on generic medicines and active pharmaceutical ingredients (APIs). With a strong operational presence across various regions in Vietnam, MEKOPHAR is renowned for its commitment to innovation and quality. The company’s core offerings include a diverse range of medications that cater to various therapeutic areas, setting it apart through rigorous quality control and adherence to international standards. Recognised for its market leadership, MEKOPHAR has achieved notable milestones, including certifications from global health authorities, which underscore its dedication to excellence in the pharmaceutical sector.
DitchCarbon Score
How does MEKOPHAR Chemical Pharmaceutical Joint Stock Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
MEKOPHAR Chemical Pharmaceutical Joint Stock Company's score of 20 is lower than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
MEKOPHAR Chemical Pharmaceutical Joint Stock Company's reported carbon emissions
MEKOPHAR Chemical Pharmaceutical Joint Stock Company, headquartered in Vietnam, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. As a result, MEKOPHAR's climate commitments and initiatives remain unclear, and there is no information available regarding any emissions inherited from a parent or related organization. The company may need to establish clear climate strategies and targets to align with industry standards and enhance its sustainability profile.
How Carbon Intensive is MEKOPHAR Chemical Pharmaceutical Joint Stock Company's Industry?
How Carbon Intensive is MEKOPHAR Chemical Pharmaceutical Joint Stock Company's Location?
MEKOPHAR Chemical Pharmaceutical Joint Stock Company's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
MEKOPHAR Chemical Pharmaceutical Joint Stock Company has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
